NASDAQ:IPSC

Century Therapeutics Stock Forecast

etoro logo Buy IPSC
*Your capital is at risk
$2.25
+0.0100 (+0.446%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of IPSC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IPSC to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Century Therapeutics, Inc. stock downgraded to Sell Candidate
(Updated on Jun 12, 2026)

Sell candidate since Jun 12, 2026

The Century Therapeutics, Inc. stock price gained 0.446% on the last trading day (Friday, 12th Jun 2026), rising from $2.24 to $2.25. During the last trading day the stock fluctuated 4.36% from a day low at $2.18 to a day high of $2.28. The price has fallen in 6 of the last 10 days and is down by -8.16% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 9 thousand more shares were traded than the day before. In total, 702 thousand shares were bought and sold for approximately $1.58 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.25% during the next 3 months and, with a 90% probability hold a price between $1.93 and $2.51 at the end of this 3-month period.

IPSC Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 8.70%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Century Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.26. On a fall, the stock will find some support from the short-term average at $2.18. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Century Therapeutics, Inc. stock

Century Therapeutics, Inc. finds support from accumulated volume at $2.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0950 between high and low, or 4.36%. For the last week, the stock has had daily average volatility of 7.72%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IPSC) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Century Therapeutics, Inc. to open at $2.24, and during the day (based on 14 day Average True Range), to move between $2.17 and $2.33, which gives a possible trading interval of +/-$0.163 (+/-7.49%) up or down from last closing price. If Century Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.26 (0.44%) than the support at $2.24 (0.44%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Century Therapeutics, Inc. stock A Buy?

Century Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.077 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $2.24 ( 0.667%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IPSC Performance

Trading levels for IPSC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.33 3.56%
R2 2.29 1.94%
R1 2.27 0.95%
Price 2.25
S1 2.20 -2.28%
S2 2.18 -3.28%
S3 2.14 -4.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.37 5.33%
R2 2.29 1.78%
R1 2.26 0.444%
Price 2.25
S1 2.24 -0.444%
S2 2.13 -5.33%
S3 2.07 -8.00%

FAQ

What is the symbol for Century Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Century Therapeutics, Inc. is IPSC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Century Therapeutics, Inc. Stock?
Century Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Century Therapeutics, Inc. Stock?
Century Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Century Therapeutics, Inc. Stock.

What's the current price of Century Therapeutics, Inc. Stock?
As of the end of day on the Jun 12, 2026, the price of an Century Therapeutics, Inc. (IPSC) share was $2.25.

What is the 52-week high and low for Century Therapeutics, Inc. Stock?
The 52-week high for Century Therapeutics, Inc. Stock is $3.03 and the 52-week low is $0.435.

What is the market capitalization of Century Therapeutics, Inc. Stock?
As of the Jun 12, 2026, the market capitalization of Century Therapeutics, Inc. is 194.781M.

When is the next earnings date for Century Therapeutics, Inc.?
The upcoming earnings date for Century Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT CENTURY THERAPEUTICS, INC.
Century Therapeutics
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting C...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE